trial
as of 2026-07-01Using Transcranial Magnetic Stimulation (TMS) to Understand 'Negative' Symptoms of Schizophrenia
NCTId NCT03648268
at a glance
— · Terminated
Enrollment 47 (actual)
Sponsored by Beth Israel Deaconess Medical Center
Primary completion 2023-12-22
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Terminated
Enrollment
47 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2019-05-02
Primary completion
2023-12-22
Eligibility
ALL · 18 Years · 55 Years
Interventions & indications
Sponsors
Beth Israel Deaconess Medical CenterLead Sponsor
Mclean HospitalCollaborator
Harvard UniversityCollaborator
Investigators
1
Roscoe O Brady, MD, PhDPrincipal Investigator
Sites
1 total
Boston, United States
Facts & assertions
4 sourced
Enrollment
47
Phase
NA
Primary Completion Date
2023-12-22
Status
TERMINATED
relationships
The graph out of here
lead_sponsor
collaborator
company
company
indication
indication
indication
indication
investigator
person